Skip to content
healthcare.dev

UPTRAVI

NDC 66215-718, Selexipag, injection, powder, for solution, from Actelion Pharmaceuticals US, Inc..

Product NDC
66215-718
Status
Listed
Labeler
Actelion Pharmaceuticals US, Inc.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214275
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66215-718 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SELEXIPAG1800 ug/10mL

Pharmacologic classes

Prostacyclin Receptor Agonist [EPC]; Prostacyclin Receptor Agonists [MoA]

Package NDCNDC-11Package
66215-718-01662150718011 VIAL, SINGLE-DOSE in 1 CARTON (66215-718-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a7a23b87-f892-4e2c-8e2e-ebf841220f90

Use it

Look up 66215-718 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66215-718 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66215-718. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.